table of content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Drug Type
1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate By Drug Type: 2017 VS 2021 VS 2028
1.2.2 By Drug Type
1.2.3 By Cancer Type
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2017-2028)
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Region
2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Region (2017-2022)
2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2023-2028)
2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics
2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Industry Trends
2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2017-2022)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2021
3.5 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2017-2022)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2023-2028)
5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2017-2022)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
8.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
9.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
9.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
10.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Detail
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.1.5 Aquila BioMedical Recent Development
11.2 BPS Bioscience, Inc.
11.2.1 BPS Bioscience, Inc. Company Detail
11.2.2 BPS Bioscience, Inc. Business Overview
11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.2.5 BPS Bioscience, Inc. Recent Development
11.3 Celentyx Ltd
11.3.1 Celentyx Ltd Company Detail
11.3.2 Celentyx Ltd Business Overview
11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.3.5 Celentyx Ltd Recent Development
11.4 Crown Bioscience, Inc.
11.4.1 Crown Bioscience, Inc. Company Detail
11.4.2 Crown Bioscience, Inc. Business Overview
11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.4.5 Crown Bioscience, Inc. Recent Development
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Detail
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.5.5 DiscoverX Corporation Recent Development
11.6 Explicyte
11.6.1 Explicyte Company Detail
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.6.5 Explicyte Recent Development
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Detail
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.7.5 Genscript Biotech Corporation Recent Development
11.8 HD Biosciences Co.
11.8.1 HD Biosciences Co. Company Detail
11.8.2 HD Biosciences Co. Business Overview
11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.8.5 HD Biosciences Co. Recent Development
11.9 Horizon Discovery Group PLC
11.9.1 Horizon Discovery Group PLC Company Detail
11.9.2 Horizon Discovery Group PLC Business Overview
11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.9.5 Horizon Discovery Group PLC Recent Development
11.10 ImmunXperts SA
11.10.1 ImmunXperts SA Company Detail
11.10.2 ImmunXperts SA Business Overview
11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.10.5 ImmunXperts SA Recent Development
11.11 Molecular Imaging, Inc.
11.11.1 Molecular Imaging, Inc. Company Detail
11.11.2 Molecular Imaging, Inc. Business Overview
11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.11.5 Molecular Imaging, Inc. Recent Development
11.12 Promega Corporation,Personalis, Inc.
11.12.1 Promega Corporation,Personalis, Inc. Company Detail
11.12.2 Promega Corporation,Personalis, Inc. Business Overview
11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.12.5 Promega Corporation,Personalis, Inc. Recent Development
11.13 STC Biologics
11.13.1 STC Biologics Company Detail
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.13.5 STC Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
